(1->4)-beta-D-glucan multiple interactions ISO RGD:2295251 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2C52-PS mRNA CTD PMID:36331819 1,2-dichloroethene decreases expression EXP 6480464 1, 2-dichloroethylene results in decreased expression of CYP2C11 protein CTD PMID:9493318 1,2-dichloroethene decreases activity EXP 6480464 1, 2-dichloroethylene results in decreased activity of CYP2C11 protein CTD PMID:9493318 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP2C11 mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP2C11 protein CTD PMID:11731036 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of CYP2C11 protein CTD PMID:11731036 , PMID:12029382 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP2C11 mRNA CTD PMID:11553364 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 , PMID:31826744 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP 6480464 Tetrachlorodibenzodioxin results in decreased activity of CYP2C11 protein CTD PMID:16781091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2295251 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2C11 mRNA CTD PMID:18467041 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2295251 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2C11 mRNA] CTD PMID:18467041 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2C mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2C11 mRNA CTD PMID:21215274 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2C11 protein] more ... CTD PMID:18079364 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [Cyclosporine results in increased expression of CYP2C11 protein] CTD PMID:28899749 2-nitrophenol increases oxidation EXP 6480464 CYP2C11 protein results in increased oxidation of 2-nitrophenol CTD PMID:20027144 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:31820026 3-methylcholanthrene multiple interactions EXP 6480464 Methylcholanthrene promotes the reaction [CYP2C11 protein results in increased oxidation of Toluene] CTD PMID:1994898 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP2C11 mRNA CTD PMID:23273579 3-methylcholanthrene decreases expression EXP 6480464 Methylcholanthrene results in decreased expression of CYP2C11 mRNA CTD PMID:10476907 , PMID:22978700 3-oxo-5beta-cholanic acid multiple interactions EXP 6480464 [CYP2C11 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis of 3-oxocholan-24-oic acid CTD PMID:18039809 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CYP2C11 mRNA CTD PMID:25380136 , PMID:30723492 5,7-dihydroxy-4'-methoxyflavone decreases activity EXP 6480464 acacetin results in decreased activity of CYP2C11 protein CTD PMID:32738202 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CYP2C11 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP2C11 mRNA CTD PMID:31881176 acetonitrile multiple interactions EXP 6480464 acetonitrile inhibits the reaction [CYP2C11 protein results in increased metabolism of 7-methoxy-4-trifluoromethylcoumarin] CTD PMID:19858067 aflatoxin B1 increases activity EXP 6480464 CYP2C11 protein results in increased activity of Aflatoxin B1 CTD PMID:11346484 all-trans-retinol multiple interactions EXP 6480464 GH1 protein promotes the reaction [Vitamin A affects the expression of and affects the activity of CYP2C11 protein], Vitamin A affects the expression of and affects the activity of CYP2C11 protein CTD PMID:15963505 alpha-hexachlorocyclohexane multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2C11 mRNA, [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2C11 protein CTD PMID:16246485 alpha-naphthoflavone multiple interactions ISO RGD:2295251 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2C11 mRNA] CTD PMID:18467041 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP2C mRNA CTD PMID:16483693 ampicillin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA CTD PMID:30545405 andrographolide decreases expression EXP 6480464 andrographolide results in decreased expression of CYP2C11 mRNA, andrographolide results in decreased expression of CYP2C11 protein CTD PMID:19041297 anthocyanin increases expression EXP 6480464 Anthocyanins results in increased expression of CYP2C mRNA CTD PMID:18803703 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with 1-phenylazo-2-naphthol] results in decreased activity of CYP2C11 protein more ... CTD PMID:21362632 more ... Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2C mRNA CTD PMID:18178546 atrazine decreases activity EXP 6480464 Atrazine results in decreased activity of CYP2C11 protein CTD PMID:9711812 benzene decreases expression EXP 6480464 Benzene results in decreased expression of CYP2C11 protein CTD PMID:8135039 benzene multiple interactions EXP 6480464 CYP2C11 protein affects the reaction [Benzene results in increased metabolism of Toluene] CTD PMID:8620572 Benzo[a]pyrene-7,8-oxide multiple interactions EXP 6480464 CYP2C11 protein promotes the reaction [EPHX1 protein affects the hydrolysis of benzo(a)pyrene 7, 8-oxide] CTD PMID:12051674 benzophenone increases expression EXP 6480464 benzophenone results in increased expression of CYP2C11 mRNA CTD PMID:14613717 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP2C mRNA, [Phenobarbital co-treated with beta-Naphthoflavone] results in decreased expression of CYP2C11 protein CTD PMID:18164116 , PMID:30842367 Bufuralol increases hydroxylation EXP 6480464 CYP2C11 protein results in increased hydroxylation of bufuralol CTD PMID:11911841 Butylbenzyl phthalate decreases activity EXP 6480464 butylbenzyl phthalate results in decreased activity of CYP2C11 protein CTD PMID:27432241 Butylparaben decreases activity EXP 6480464 butylparaben results in decreased activity of CYP2C11 protein CTD PMID:27432241 C.I. Natural Red 20 decreases activity EXP 6480464 shikonin results in decreased activity of CYP2C11 protein CTD PMID:28941798 cafestol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] results in decreased expression of CYP2C11, [cafestol co-treated with kahweol] results in decreased expression of CYP2C11 protein CTD PMID:11346484 , PMID:9744531 carvedilol increases metabolic processing EXP 6480464 CYP2C11 protein results in increased metabolism of carvedilol CTD PMID:29415952 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of CYP2C mRNA CTD PMID:18500788 chenodeoxycholic acid decreases activity EXP 6480464 Chenodeoxycholic Acid results in decreased activity of CYP2C11 protein CTD PMID:8889968 chlorpromazine decreases expression EXP 6480464 Chlorpromazine results in decreased expression of CYP2C mRNA, Chlorpromazine results in decreased expression of CYP2C11 mRNA CTD PMID:18246545 chlorzoxazone affects metabolic processing EXP 6480464 CYP2C11 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 cholic acid decreases activity EXP 6480464 Cholic Acid results in decreased activity of CYP2C11 protein CTD PMID:8889968 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CYP2C11 mRNA, [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CYP2C11 protein CTD PMID:24403518 cimetidine multiple interactions EXP 6480464 Cimetidine inhibits the reaction [CYP2C11 protein results in increased glutathionylation of lamotrigine] CTD PMID:19961160 ciprofloxacin decreases expression EXP 6480464 Ciprofloxacin results in decreased expression of CYP2C11 mRNA CTD PMID:12621481 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CYP2C mRNA CTD PMID:22023808 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP2C mRNA more ... CTD PMID:15788368 , PMID:17602206 clofibric acid decreases expression EXP 6480464 Clofibric Acid results in decreased expression of CYP2C11 mRNA CTD PMID:15788368 clotrimazole multiple interactions EXP 6480464 Clotrimazole inhibits the reaction [CYP2C11 protein results in increased metabolism of 7-methoxy-4-trifluoromethylcoumarin] CTD PMID:19858067 clotrimazole decreases expression EXP 6480464 Clotrimazole results in decreased expression of CYP2C11 protein CTD PMID:7986207 copper atom decreases expression EXP 6480464 Copper results in decreased expression of CYP2C mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of CYP2C mRNA CTD PMID:22465980 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP2C11 mRNA CTD PMID:35301062 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of CYP2C mRNA CTD PMID:18480146 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CYP2C11 mRNA CTD PMID:16019949 cyclophosphamide increases metabolic processing EXP 6480464 CYP2C11 results in increased metabolism of Cyclophosphamide CTD PMID:20566340 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CYP2C11 protein CTD PMID:28899749 cyclosporin A multiple interactions EXP 6480464 Nifedipine promotes the reaction [Cyclosporine results in increased expression of CYP2C11 protein], Verapamil inhibits the reaction [Cyclosporine results in increased expression of CYP2C11 protein] CTD PMID:28899749 dehydroepiandrosterone sulfate multiple interactions EXP 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP2C11 protein CTD PMID:25786523 deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of CYP2C11 protein CTD PMID:10453939 deoxycholic acid decreases activity EXP 6480464 Deoxycholic Acid results in decreased activity of CYP2C11 protein CTD PMID:8889968 deoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of CYP2C11 protein] CTD PMID:10453939 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP2C11, Dexamethasone results in increased expression of CYP2C11 protein CTD PMID:15890479 , PMID:19041297 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of CYP2C mRNA CTD PMID:15102944 dibutyl phthalate decreases activity EXP 6480464 Dibutyl Phthalate results in decreased activity of CYP2C11 protein CTD PMID:27432241 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of CYP2C mRNA CTD PMID:18636392 dichlorine decreases expression EXP 6480464 Chlorine results in decreased expression of CYP2C mRNA CTD PMID:18636392 diethyl phthalate decreases activity EXP 6480464 diethyl phthalate results in decreased activity of CYP2C11 protein CTD PMID:27432241 dimethyl sulfoxide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [CYP2C11 protein results in increased metabolism of 7-methoxy-4-trifluoromethylcoumarin] CTD PMID:19858067 dipropyl phthalate decreases activity EXP 6480464 di-n-propylphthalate results in decreased activity of CYP2C11 protein CTD PMID:27432241 disulfiram decreases activity EXP 6480464 Disulfiram results in decreased activity of CYP2C11 protein CTD PMID:9393675 disulfiram decreases expression EXP 6480464 Disulfiram results in decreased expression of CYP2C11 protein CTD PMID:9393675 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CYP2C11 mRNA, Doxorubicin results in increased expression of CYP2C11 protein CTD PMID:19796650 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP2C11 mRNA CTD PMID:29038839 ethanol multiple interactions EXP 6480464 Ethanol promotes the reaction [CYP2C11 protein results in increased oxidation of Toluene] CTD PMID:1994898 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP2C11 mRNA CTD PMID:35301062 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CYP2C11 mRNA CTD PMID:23273579 ethylbenzene decreases expression EXP 6480464 ethylbenzene results in decreased expression of CYP2C11 protein CTD PMID:8135039 ethylparaben decreases activity EXP 6480464 ethyl-p-hydroxybenzoate results in decreased activity of CYP2C11 protein CTD PMID:27432241 farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP2C11 protein CTD PMID:15840382 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA CTD PMID:18253720 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CYP2C mRNA CTD PMID:18035473 fluconazole decreases expression EXP 6480464 Fluconazole results in decreased expression of CYP2C mRNA CTD PMID:16643972 fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [CYP2C11 protein results in increased metabolism of 7-methoxy-4-trifluoromethylcoumarin] CTD PMID:19858067 fulvestrant increases expression EXP 6480464 fulvestrant results in increased expression of CYP2C11 mRNA CTD PMID:16837770 Furafylline decreases activity EXP 6480464 furafylline results in decreased activity of CYP2C11 protein CTD PMID:15879494 furan decreases expression EXP 6480464 furan results in decreased expression of CYP2C mRNA, furan results in decreased expression of CYP2C11 mRNA CTD PMID:15120968 , PMID:25539665 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2C11 protein] CTD PMID:18079364 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP2C11 mRNA, Hexachlorocyclohexane results in increased expression of CYP2C11 protein CTD PMID:11684361 , PMID:16837770 gemfibrozil decreases expression EXP 6480464 Gemfibrozil results in decreased expression of CYP2C11 protein CTD PMID:9209713 gentamycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA CTD PMID:30545405 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP2C11 mRNA CTD PMID:24136188 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CYP2C11 mRNA CTD PMID:16771604 inulin multiple interactions ISO RGD:2295251 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP2C52-PS mRNA CTD PMID:36331819 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of CYP2C11 mRNA CTD PMID:18725507 kahweol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] results in decreased expression of CYP2C11, [cafestol co-treated with kahweol] results in decreased expression of CYP2C11 protein CTD PMID:11346484 , PMID:9744531 ketoconazole multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP2C11 protein results in increased metabolism of 7-methoxy-4-trifluoromethylcoumarin] CTD PMID:19858067 ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP2C11 protein CTD PMID:15879494 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA CTD PMID:18544905 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CYP2C11 mRNA, [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CYP2C11 protein CTD PMID:24403518 lamotrigine increases activity EXP 6480464 CYP2C11 protein results in increased activity of lamotrigine CTD PMID:19961160 lamotrigine increases glutathionylation EXP 6480464 CYP2C11 protein results in increased glutathionylation of lamotrigine CTD PMID:19961160 lamotrigine multiple interactions EXP 6480464 Cimetidine inhibits the reaction [CYP2C11 protein results in increased glutathionylation of lamotrigine] CTD PMID:19961160 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of CYP2C11 mRNA CTD PMID:23391631 lithocholic acid increases metabolic processing EXP 6480464 CYP2C11 protein results in increased metabolism of Lithocholic Acid CTD PMID:18039809 lithocholic acid decreases activity EXP 6480464 Lithocholic Acid results in decreased activity of CYP2C11 protein CTD PMID:8889968 lithocholic acid multiple interactions EXP 6480464 [CYP2C11 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis of 3-oxocholan-24-oic acid CTD PMID:18039809 Luteolin 7-methyl ether decreases activity EXP 6480464 hydroxygenkwanin results in decreased activity of CYP2C11 protein CTD PMID:34843882 m-xylene decreases expression EXP 6480464 3-xylene results in decreased expression of CYP2C mRNA CTD PMID:12815608 MeIQx increases expression EXP 6480464 2-amino-3 more ... CTD PMID:14965361 methapyrilene decreases activity EXP 6480464 Methapyrilene results in decreased activity of CYP2C11 protein CTD PMID:9928682 methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP2C11 protein CTD PMID:12814958 , PMID:15879494 methoxychlor increases metabolic processing EXP 6480464 CYP2C11 protein results in increased metabolism of Methoxychlor CTD PMID:14613717 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP2C11 mRNA CTD PMID:14613717 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of CYP2C11 protein CTD PMID:12919727 methoxychlor decreases activity EXP 6480464 Methoxychlor results in decreased activity of CYP2C11 protein CTD PMID:8114062 methylarsonic acid increases expression EXP 6480464 monomethylarsonic acid results in increased expression of CYP2C11 mRNA CTD PMID:17481689 metronidazole multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA CTD PMID:30545405 mitomycin C decreases activity EXP 6480464 Mitomycin results in decreased activity of CYP2C11 protein CTD PMID:15696929 mono(2-ethylhexyl) phthalate decreases activity EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased activity of CYP2C11 protein CTD PMID:27432241 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of CYP2C11 mRNA CTD PMID:8496838 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of CYP2C11 mRNA more ... CTD PMID:11089541 more ... monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with GH1 protein] results in decreased splicing of CYP2C11 mRNA more ... CTD PMID:11089541 more ... monosodium L-glutamate decreases activity EXP 6480464 Sodium Glutamate results in decreased activity of CYP2C11 protein CTD PMID:7476908 , PMID:8496838 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2C11 mRNA more ... CTD PMID:16246485 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CYP2C mRNA more ... CTD PMID:14965361 more ... N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of CYP2C mRNA, Dimethylnitrosamine results in decreased expression of CYP2C11 mRNA CTD PMID:17072980 , PMID:25380136 neomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA CTD PMID:30545405 nevirapine affects binding EXP 6480464 Nevirapine binds to CYP2C11 protein CTD PMID:22793666 nifedipine multiple interactions EXP 6480464 Nifedipine promotes the reaction [Cyclosporine results in increased expression of CYP2C11 protein] CTD PMID:28899749 Nonylphenol decreases activity EXP 6480464 nonylphenol results in decreased activity of CYP2C11 protein CTD PMID:11731036 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of CYP2C11 protein CTD PMID:11731036 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of CYP2C mRNA, ochratoxin A results in decreased expression of CYP2C11 mRNA CTD PMID:18417182 , PMID:30449730 ochratoxin A affects methylation EXP 6480464 ochratoxin A affects the methylation of CYP2C11 promoter CTD PMID:30449730 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CYP2C mRNA CTD PMID:16251485 oltipraz affects metabolic processing EXP 6480464 CYP2C11 protein affects the metabolism of oltipraz CTD PMID:15831204 , PMID:15920769 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of CYP2C11 mRNA CTD PMID:23439660 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of CYP2C mRNA CTD PMID:18636392 paracetamol multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP2C11 mRNA CTD PMID:17126469 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP2C11 mRNA CTD PMID:17126469 , PMID:21807079 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP2C mRNA CTD PMID:17366322 Paraoxon-methyl increases chemical synthesis EXP 6480464 CYP2C11 protein results in increased chemical synthesis of methylparaoxon CTD PMID:22271348 parathion-methyl increases metabolic processing EXP 6480464 CYP2C11 protein results in increased metabolism of Methyl Parathion CTD PMID:22271348 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:2295251 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2C52-PS mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP2C52-PS mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2C11 protein CTD PMID:34958885 phenacetin affects metabolic processing EXP 6480464 CYP2C11 protein affects the metabolism of Phenacetin CTD PMID:15879494 phenobarbital multiple interactions EXP 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP2C11 protein more ... CTD PMID:1994898 more ... phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP2C11 protein CTD PMID:30842367 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP2C mRNA more ... CTD PMID:19162173 more ... phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of CYP2C11 protein CTD PMID:16781091 pirinixic acid decreases expression ISO RGD:2295251 6480464 pirinixic acid results in decreased expression of CYP2C11 protein CTD PMID:17405874 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP2C mRNA, pirinixic acid results in decreased expression of CYP2C11 protein CTD PMID:19162173 , PMID:9209713 poly(I:C) decreases expression EXP 6480464 Poly I-C results in decreased expression of CYP2C11 mRNA CTD PMID:23939143 polymyxin B2 multiple interactions EXP 6480464 Polymyxin B inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2C11 protein] CTD PMID:18079364 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2C mRNA CTD PMID:19162173 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP2C11 protein CTD PMID:33150952 profenofos decreases expression EXP 6480464 profenofos results in decreased expression of CYP2C11 mRNA, profenofos results in decreased expression of CYP2C11 protein CTD PMID:18828448 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of CYP2C11 protein CTD PMID:7986207 propylbenzene decreases expression EXP 6480464 n-propylbenzene results in decreased expression of CYP2C11 protein CTD PMID:8135039 propylparaben decreases activity EXP 6480464 propylparaben results in decreased activity of CYP2C11 protein CTD PMID:27432241 pyrene affects expression EXP 6480464 pyrene affects the expression of CYP2C11 mRNA CTD PMID:30240548 pyrimidin-2-amine affects binding EXP 6480464 2-aminopyrimidine analog binds to CYP2C11 protein CTD PMID:19317514 quinine decreases activity EXP 6480464 Quinine results in decreased activity of CYP2C11 protein CTD PMID:12814958 , PMID:15879494 riddelliine decreases expression EXP 6480464 riddelliine results in decreased expression of CYP2C mRNA CTD PMID:18047722 , PMID:18047727 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CYP2C11 mRNA CTD PMID:28374803 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of CYP2C mRNA, sevoflurane affects the expression of CYP2C11 mRNA CTD PMID:15967596 Shikonin decreases activity EXP 6480464 shikonin results in decreased activity of CYP2C11 protein CTD PMID:28941798 simazine decreases activity EXP 6480464 Simazine results in decreased activity of CYP2C11 protein CTD PMID:9711812 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP2C11 mRNA, [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP2C11 protein CTD PMID:24815820 styrene decreases expression EXP 6480464 Styrene results in decreased expression of CYP2C11 mRNA CTD PMID:16418063 styrene oxide multiple interactions EXP 6480464 CYP2C11 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] CTD PMID:12051674 Sudan I decreases activity EXP 6480464 1-phenylazo-2-naphthol results in decreased activity of CYP2C11 protein CTD PMID:26845733 Sudan I multiple interactions EXP 6480464 [aristolochic acid I co-treated with 1-phenylazo-2-naphthol] results in decreased activity of CYP2C11 protein CTD PMID:26845733 Sudan III multiple interactions EXP 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased activity of CYP2C11 protein] more ... CTD PMID:15788368 Sudan III decreases expression EXP 6480464 sudan III results in decreased expression of CYP2C11 mRNA CTD PMID:15788368 sulfaphenazole decreases expression EXP 6480464 Sulfaphenazole results in decreased expression of CYP2C11 CTD PMID:15890479 sunitinib decreases expression EXP 6480464 sunitinib results in decreased expression of CYP2C11 mRNA CTD PMID:26797788 tamoxifen multiple interactions EXP 6480464 Tamoxifen promotes the reaction [testosterone enanthate results in increased expression of CYP2C11 protein] CTD PMID:8573203 taurocholic acid decreases activity EXP 6480464 Taurocholic Acid results in decreased activity of CYP2C11 protein CTD PMID:8889968 testosterone affects metabolic processing EXP 6480464 CYP2C11 protein affects the metabolism of Testosterone CTD PMID:15879494 testosterone increases expression EXP 6480464 Testosterone results in increased expression of CYP2C11 mRNA CTD PMID:16837770 testosterone enanthate increases expression EXP 6480464 testosterone enanthate results in increased expression of CYP2C11 mRNA, testosterone enanthate results in increased expression of CYP2C11 protein CTD PMID:8573203 , PMID:8819526 testosterone enanthate multiple interactions EXP 6480464 Tamoxifen promotes the reaction [testosterone enanthate results in increased expression of CYP2C11 protein] CTD PMID:8573203 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP2C protein more ... CTD PMID:12629582 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP2C11 mRNA CTD PMID:31150632 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CYP2C mRNA CTD PMID:12734012 , PMID:17805973 tetrachloromethane decreases activity EXP 6480464 Carbon Tetrachloride results in decreased activity of CYP2C11 protein CTD PMID:14706259 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP2C11 mRNA CTD PMID:23411599 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP2C mRNA CTD PMID:28943392 toluene increases oxidation EXP 6480464 CYP2C11 protein results in increased oxidation of Toluene CTD PMID:1994898 toluene affects expression EXP 6480464 Toluene affects the expression of CYP2C mRNA CTD PMID:18653662 toluene affects metabolic processing EXP 6480464 CYP2C11 protein affects the metabolism of Toluene CTD PMID:8620572 toluene multiple interactions EXP 6480464 CYP2C11 protein affects the reaction [Benzene results in increased metabolism of Toluene] more ... CTD PMID:1994898 , PMID:8620572 torasemide affects metabolic processing EXP 6480464 CYP2C11 protein affects the metabolism of Torsemide CTD PMID:15890479 trans-1,2-dichloroethene decreases expression EXP 6480464 1, 2-dichloroethylene results in decreased expression of CYP2C11 protein CTD PMID:9493318 trans-1,2-dichloroethene decreases activity EXP 6480464 1, 2-dichloroethylene results in decreased activity of CYP2C11 protein CTD PMID:9493318 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of CYP2C mRNA CTD PMID:17553608 trichloroethene multiple interactions EXP 6480464 CYP2C11 protein affects the reaction [Trichloroethylene results in increased metabolism of Toluene] CTD PMID:8620572 trimethylarsine oxide increases expression EXP 6480464 trimethylarsine oxide results in increased expression of CYP2C11 mRNA CTD PMID:17481689 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP2C11 protein CTD PMID:32519852 uranium atom multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP2C11 mRNA CTD PMID:17126469 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of CYP2C11 protein] CTD PMID:10453939 vancomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA CTD PMID:30545405 verapamil multiple interactions EXP 6480464 Verapamil inhibits the reaction [Cyclosporine results in increased expression of CYP2C11 protein] CTD PMID:28899749 warfarin increases metabolic processing EXP 6480464 CYP2C11 protein results in increased metabolism of Warfarin CTD PMID:30724651 zinc atom multiple interactions EXP 6480464 Zinc deficiency results in decreased expression of and results in decreased activity of CYP2C11 protein CTD PMID:11705462 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CYP2C11 mRNA CTD PMID:11705462 zinc(0) multiple interactions EXP 6480464 Zinc deficiency results in decreased expression of and results in decreased activity of CYP2C11 protein CTD PMID:11705462 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CYP2C11 mRNA CTD PMID:11705462
